The Risk of Breast Cancer According to Mutation Type and Position in Carriers of a Pathogenic Variant in <i>BRCA1</i>.

Curr Oncol · 2025 · PMC12731516 · PMID 41440233

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

borderline significantno p-value reported

Using exon 12 as reference group, there was a borderline significant increased breast cancer risk with PVs in exon 16 (HR = 2.44; 95% CI 1.01–5.88).

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

The Risk of Breast Cancer According to Mutation Type and Position in Carriers of a Pathogenic Variant in &lt;i&gt;BRCA1&lt;/i&gt;.

The sentences

The Risk of Breast Cancer According to Mutation Type and Position in Carriers of a Pathogenic Variant in <i>BRCA1</i>.